Are there any issues other than supply that are preventing a faster rollout of the Pfizer, Moderna and J&J vaccines?

None - it is purely availability of the vaccines themselves. The rest of the infrastructure is there to do 1 million doses a day.

The opposite for me - I wanted to cancel but it forced me to re-schedule, but if your call response is as efficient as mine then it's simple to do on the phone.

J&J is not approved yet in the UK either, although no idea if that would mean it were available anytime sooner... seems not.

Moderna jabs started today in Wales. Not sure why not UK wide.

If the direction of the news is any indication, people might start asking why all the eggs were put in one basket.

The UK's eggs were not all "put in one basket": we've ordered vaccines from several manufacturers.

And I think it's clear that the UK's strategy - some said gamble - has paid off handsomely, with infections, hospitalisations and deaths down by 95% while mainland Europe suffers a new wave and a vaccine shortage.

Today's headlines are a great shame without doubt. However, I do not think there is any doubt now that AZ and the other vaccines have saved many lives here. The only thing I would say (and very much with the benefit of hindsight), it was a mistake starting trials with children when they are at such a low risk from COVID and appear not to be very involved with spreading it either.

I would disagree with that as the target of giving every adult in the UK at least 1 dose by the end of July is entirely based on the AZ vaccine being used. The other two vaccines were ordered in comparatively low amounts, so yes I would call that putting all your eggs in one basket.

I'm not trying to compare us to Europe, just simply pointing out that if the AZ vaccine is not usable on under 50's we'll be in a tricky spot for timelines and vaccine deployment.

Anyone that was around with girls in the early 90s may remember the blood clot scare with ones that were on the pill. Blood clots have always been a thing. I cannot find it now but there some Aussie doctor also saying that Pfizer has had some issues there too. Whether the data is there to support either who knows but as Sherlock Holmes wisely said in A Scandal in Bohemia “I have no data yet. It is a capital mistake to theorise before one has data. Insensibly one begins to twist facts to suit theories, instead of theories to suit facts.”

The UK ordered a total of 457 million doses from 8 different manufacturers, of which only 100 million were AZ. I really don't think that can be considered to be one basket.

It just so happened that the AZ vaccine was one of the first actually available and the one that has been administered the most, which isn't the same thing.

The European Medicines Agency has just had a press conference and have said that they will list the blood clots as "very rare side effects" and that the benefits continue to outweigh the risks, therefore, they will continue to recommend its use.

And the UK has just said for people under 30 the risks outweigh the benefits. Below is Jonathan Van-Tam's slide he just presented:
https://cimg1.ibsrv.net/gimg/www.fly...bdc6780bc1.png

Some daily data:

Cases 2,763 (4,052 last Wednesday)
Deaths 45 (43)
Patients admitted 256 (364 on the 23rd)
Patients on ventilation 469 (582 on the 28th)

The 7 day rolling daily average is now down 36.6% on the previous 7 days.

Out of curiousity, do you/anyone happen to know how this would compare to a "bad flu" season?